Role of tumor heterogeneity in drug resistance
Journal: Global Journal of Cancer Therapy (Vol.3, No. 1)Publication Date: 2017-12-30
Abstract
Cancer is a leading cause of death in men worldwide and the major cause of cancer related death is drug resistance [1,2]. In past few years, scientists have established tumor heterogeneity as a phenomenon of critical importance in the natural history of individual neoplasms and drug resistance [3-5]. The concept of tumor heterogeneity has a major impact on therapeutic approaches [6-9]. Drug resistance creates difficulty in cancer treatment and is directly linked to the tumor progression and poorer prognosis. As tumor heterogeneity is very common in almost all solid tumors, cancer therapy needs to become more personalized, selective, and specific [10-13]. Understanding the mechanisms of tumor heterogeneity and drug resistance will provide sustenance for the future development of personalized cancer medicine.
Other Latest Articles
- MEK Inhibitors in Combination with Immune Checkpoint Inhibition: Should we be Chasing Colorectal Cancer or the KRAS Mutant Cancer
- Angiosarcoma of the Scalp and Face: A Hard to Treat Tumor
- The Promise of Disease Management in Greece
- Abrikossoff’s Tumour Mimicking a Neoplastic Tumour of the Breast: A Case Report
- The Role of Decavanadate in Anti- Tumour Activity
Last modified: 2018-10-05 21:11:18